Discover @ Loyola University Chicago Health Sciences Division

Results (30)

Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions.

Journal Article

Solanki, AA; Mysz, ML; Patel, R; Surucu, M; Kang, H; Plypoo, A; Bajaj, A; Korpics, M; Martin, B; Hentz, C; more...
Advances in radiation oncology (2018)

Find It @ Loyola | Save

Thirty-day hospital revisits after prostate brachytherapy: who is at risk?

Journal Article

Li, B; Kirshenbaum, EJ; Blackwell, RH; Gange, WS; Saluk, J; Zapf, MAC; Kothari, AN; Flanigan, RC; Gupta, GN
Prostate international (2018)

Find It @ Loyola | Save

Unintended Consequences After Postoperative Ileus in Spinal Fusion Patients.

Journal Article

Swong, K; Johans, S; Molefe, A; Hofler, RC; Wemhoff, M; Kuo, P; Germanwala, A
World neurosurgery (2018)

Find It @ Loyola | Save

Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells

Journal Article

Moore, T; Wagner, C. R.; Scurti, G. M.; Hutchens, K. A.; Godellas, C; Clark, A. L.; Kolawole, E. M.; Hellman, L. M.; Singh, N. K.; Huyke, F. A.; more...
Cancer immunology, immunotherapy : CII (2018)

Find It @ Loyola | Save

Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIdelta expression in the aged atrium

Journal Article

Gao, X; Wu, X; Yan, J.; Zhang, J; Zhao, W; DeMarco, D.; Zhang, Y; Bakhos, M; Mignery, G.; Sun, J; more...
Cardiovascular research (2018)

Find It @ Loyola | Save

The LACE Score as a Tool to Identify Radical Cystectomy Patients at Increased Risk of 90-Day Readmission and Mortality.

Journal Article

Saluk, JL; Blackwell, RH; Gange, WS; Zapf, MAC; Kothari, AN; Kuo, PC; Quek, ML; Flanigan, RC; Gupta, GN
Current urology (2018)

Find It @ Loyola | Save

Racial and Ethnic Postoperative Outcomes After Surgery: The Hispanic Paradox.

Journal Article

Eguia, E; Cobb, AN; Kirshenbaum, EJ; Afshar, M; Kuo, PC
The Journal of surgical research (2018)

Find It @ Loyola | Save

Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival.